Statin intolerance: now a solved problem
- PMID: 22120862
- DOI: 10.4103/0022-3859.90085
Statin intolerance: now a solved problem
Abstract
Statins are the most effective and widely used drugs for treating dyslipidemia, a major risk factor for coronary heart disease. These are one of the safest hypolipidemic drugs but many patients are bound to discontinue statins due to their side effects. Hepatotoxicity, myotoxicity and peripheral neuropathy are important out of them. Discontinuation of statins leads to dylipidemia and its grave consequences. Hence, there should be enough strategies for statin intolerant patients, so that they can be saved from these consequences. These side effects can be avoided by the awareness of certain factors viz. potential drug interactions and dose adjustment according to patho-physiology of the patient. Baseline investigations for liver function and muscle toxicity should be done before initiating statin therapy. Here, we are discussing various options for statin intolerant hyperlipidemic patients such as lower and intermittent dosing of statins, alternate hypolipidemic drugs, red yeast rice, supplementation with coenzyme Q10 and vitamin D. A number of hypolipidemic drugs are in trial phases and hold promise for statin intolerant patients.
Similar articles
-
Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.Can J Physiol Pharmacol. 2014 Jun;92(6):481-9. doi: 10.1139/cjpp-2013-0430. Epub 2014 Apr 28. Can J Physiol Pharmacol. 2014. PMID: 24896301
-
Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.Intern Med J. 2019 Sep;49(9):1081-1091. doi: 10.1111/imj.14429. Intern Med J. 2019. PMID: 31507054 Review.
-
Strategies to preserve the use of statins in patients with previous muscular adverse effects.Am J Health Syst Pharm. 2012 Feb 15;69(4):291-300. doi: 10.2146/ajhp100700. Am J Health Syst Pharm. 2012. PMID: 22302254 Review.
-
Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.Am J Cardiol. 2010 Jan 15;105(2):198-204. doi: 10.1016/j.amjcard.2009.08.672. Epub 2009 Nov 26. Am J Cardiol. 2010. PMID: 20102918 Clinical Trial.
-
Management of the patient with statin intolerance.Curr Atheroscler Rep. 2010 Jan;12(1):48-57. doi: 10.1007/s11883-009-0077-8. Curr Atheroscler Rep. 2010. PMID: 20425271 Review.
Cited by
-
The M2 module of the Cys-His-rich domain (CHRD) of PCSK9 protein is needed for the extracellular low-density lipoprotein receptor (LDLR) degradation pathway.J Biol Chem. 2012 Dec 21;287(52):43492-501. doi: 10.1074/jbc.M112.394023. Epub 2012 Oct 26. J Biol Chem. 2012. PMID: 23105118 Free PMC article.
-
Effect of Methanolic Leaf Extract of Talinum triangulare (Jacq). Willd. on Biochemical Parameters in Diet induced Dyslipidemia Wistar Rats.Pharmacogn Mag. 2016 Oct-Dec;12(48):333-339. doi: 10.4103/0973-1296.192194. Pharmacogn Mag. 2016. PMID: 27867278 Free PMC article.
-
Statins Neuromuscular Adverse Effects.Int J Mol Sci. 2022 Jul 28;23(15):8364. doi: 10.3390/ijms23158364. Int J Mol Sci. 2022. PMID: 35955495 Free PMC article. Review.
-
The Targeting of Native Proteins to the Endoplasmic Reticulum-Associated Degradation (ERAD) Pathway: An Expanding Repertoire of Regulated Substrates.Biomolecules. 2021 Aug 11;11(8):1185. doi: 10.3390/biom11081185. Biomolecules. 2021. PMID: 34439852 Free PMC article. Review.
-
Peripheral neuropathy induced by red yeast rice in a patient with a known small bowel gastrointestinal tumour.BMJ Case Rep. 2013 Apr 5;2013:bcr2013009060. doi: 10.1136/bcr-2013-009060. BMJ Case Rep. 2013. PMID: 23563686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical